Dexcom G6 CGM Device for Non-Insulin Treated Type 2 Diabetes Care

This study focuses on the Dexcom G6 Continuous Glucose Monitoring system, a device designed to help manage Type 2 Diabetes in patients who are not using insulin therapy. The main goal is to understand how well this device works in everyday care and how it can benefit patients. The study involves individuals with Type 2 Diabetes, aiming to improve their care and address the challenges associated with managing blood sugar levels without insulin. This research is important as it could lead to better ways to monitor and control blood sugar levels, ultimately improving the quality of life for those with Type 2 Diabetes. During the study, participants wear the Dexcom G6 device, which continuously monitors their blood glucose levels. The study has two phases. In the first phase, lasting 10 days, participants cannot see the data from the device and continue their usual care, including twice-daily glucose checks. In the second phase, lasting three months, both participants and their healthcare providers can see the data. The device's effectiveness is measured by changes in average glucose levels, glucose variability, and the time spent within the acceptable glucose range (between 80-180 mg/dl). Throughout the study, participants receive usual care, including lifestyle education, virtual support, medical visits, medication interventions, and nursing support.